Resigratinib
Resigratinib (KIN-3248) is a small molecule inhibitor targeting fibroblast growth factor receptor (FGFR) tyrosine kinases, designed for antineoplastic research. It is utilized in preclinical studies to investigate FGFR-driven tumorigenesis in both cellular assays and animal models, focusing on cancers with FGFR alterations.
Product Specifications
CAS Number
2750709-91-0
Product Name Alternative
KIN3248, KIN-3248
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.58% (May vary between batches)
Solubility
DMSO:80 mg/mL (152.81 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.55 mM)
Smiles
N (C) C=1N (N=C (C#CC=2C (F) =C3C (=CC2F) N (C=N3) C4CC4) C1C (N) =O) [C@H]5C[C@H] (COC) N (C (C=C) =O) C5
Molecular Formula
C26H27F2N7O3
Molecular Weight
523.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr2115-500gEcoli 500 µg (E. coli)
Recombinant Yersinia Enterocolitica nudC Protein (aa 1-261) (strain 8081)
Sign In for Pricing
View Details 
MBS3800788-01 48 Well
Human Complement Factor D/Adipsin, CFD (Adipsin) ELISA Kit
Sign In for Pricing
View Details MBS3800788-02 96 Well
Human Complement Factor D/Adipsin, CFD (Adipsin) ELISA Kit
Sign In for Pricing
View Details MBS3800788-03 5x 96 Well
Human Complement Factor D/Adipsin, CFD (Adipsin) ELISA Kit
Sign In for Pricing
View Details MBS3800788-04 10x 96 Well
Human Complement Factor D/Adipsin, CFD (Adipsin) ELISA Kit
Sign In for Pricing
View Details